Biopharmas raising money in public or private financings, including: Aardvark, Alzamend, Apollomics, Cassava, Medigene, Optinose, Organovo, Pacira, Verona, X4.

Med-tech firms raising money in public or private financings, including: R3 Vascular, Rxsight, Tivic Health.

Biopharmas raising money in public or private financings, including: Medigene, Organon, Swedish Orphan, Think Bioscience.

Med-tech firms raising money in public or private financings, including: Nami Surgical.

Memo Therapeutics AG has added a further CHF20 million (US$22 million) to its series C, bringing the total for the round to CHF45 million and enabling the company to expand the phase II trial of its lead program, AntiBKV, in neutralizing BK virus infection in immune compromised kidney transplant recipients.

Biopharmas raising money in public or private financings, including: Ainos, Allarity, Alzamend, Bioversys, Eledon, Organon, Overt, Palisade, TC.

Med-tech firms raising money in public or private financings, including: Averto Medical, Lucid Diagnostics, Precipio, Rad AI.